Pharmacy
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?


Article ID

Home
General Pharmacy
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

The Best of 2009
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all

Articles: Major Studies



Latest () Month's Top Read Top 50 of Year  
Receive free subspecialty "5-minute updates" via email
Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring
Gilead, 07/22/09    Free full text
Sponsor
Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
Roche, 07/21/09    Free full text
Human genome sciences and glaxosmithkline announce positive phase 3 study results for benlysta
Human Genome Sciences, 07/21/09    Free full text
Pharmacological efficacy and safety profile of taranabant in preclinical species
Drug Development Research, 07/16/09
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: Interaction studies with citalopram
European Neuropsychopharmacology, 07/16/09
Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study
Expert Opinion in Pharmacotherapy, 07/15/09
Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
BMC Pediatrics, 07/14/09    Free full text
The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review
International Journal of Pharmacy Practice, 07/13/09
Sex Differences in Inappropriate Drug Use: a Register-Based Study of Over 600,000 Older People
Annals of Pharmacotherapy, 07/13/09
24-Hydroxycholesterol Sulfation by Human Cytosolic Sulfotransferases: Formation of Monosulfates and Disulfates, Molecular Modeling, Sulfatase Sensitivity and Inhibition of LXR Activation
Drug Metabolism and Disposition, 07/13/09
A Tale of Two Techniques
Pharmaceutical Technology, 07/10/09    Free full text
Drug delivery for in vitro fertilization: Rationale, current strategies and challenges
Advanced Drug Delivery Reviews, 07/08/09
Landmark study for GSK's cervical cancer vaccine published in The Lancet
GlaxoSmithKline, 07/08/09    Free full text
Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases
Amgen, 07/08/09    Free full text
DuoCort: New chronotherapy for adrenal insufficiency
b3c newswire, 07/07/09
Studies suggesting potential link between insulin glargine and cancer prompt call for further research
American Pharmacists Association, 07/06/09    Free full text
Four flavonoids from Echinosophora koreensis and their effects on alcohol metabolizing enzymes
Archives of Pharmacal Research, 07/06/09    Free full text
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
Genentech, 07/06/09    Free full text
DeCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
deCODE genetics, 07/02/09    Free full text
Study Showed VYVANSE (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
Shire, 07/02/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
172 Available Pages
First    Prev    6      7      8      9      10      11      12      13      14      15      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.